Canine Atopic Dermatitis: Multimodal Treatment—Environmental, Dietary, Medical (Apoquel, Cyclosporine), and Topical

Canine atopic dermatitis (cAD) is a chronic, pruritic, inflammatory skin disease with genetic predisposition and environmental allergen sensitization. Management is lifelong and multimodal.

Medical Management

• Environmental Control: HEPA filters, frequent washing of bedding, limit outdoor exposure during high pollen, acaricide treatment for dust mites.
• Dietary Trial: 8–12 week strict elimination diet (novel/hydrolyzed protein) to rule out food allergy. Challenge to confirm.
• Anti-Pruritics:
  • Apoquel (oclacitinib) — JAK1 inhibitor; rapid onset (4h); daily.
  • Cytopoint (lokivetmab) — anti-IL-31 monoclonal antibody; SC injection q4–8wks.
  • Corticosteroids (prednisone) — short-term only; side effects with chronic use.
  • Cyclosporine — calcineurin inhibitor; 4–6 weeks for effect; monitoring needed.
• Antimicrobials: Treat secondary pyoderma (Staph) and Malassezia overgrowth.

Topical Therapy

• Medicated shampoos (chlorhexidine, miconazole, phytosphingosine, ceramides) 2–3×/week.
• Leave-on conditioners, sprays, mousses for barrier repair.

Adjuncts

• Omega-3 fatty acids (high-dose EPA/DHA).
• Probiotics (strain-specific evidence emerging).
• Allergen-specific immunotherapy (ASIT) — only disease-modifying; 60–70% response.

Lifestyle

Regular grooming, nail trims, Elizabethan collar if self-trauma, stress reduction (enrichment, routine).

Veterinary dermatologist referral for refractory cases.